Peptide therapy glossary

Peptide therapy glossary: terms patients should know before online care

A clinician-safe glossary for online peptide therapy terms, including active ingredient, route, compounded medication, FDA-approved label, contraindication, side effects, pharmacy quality, and follow-up.

Educational guideUpdated May 15, 2026

How to use the glossary

1

Start with the exact active ingredient: semaglutide, tirzepatide, sermorelin, bremelanotide/PT-141, glutathione, NAD+, GHK-Cu, methylene blue, or another product.

2

Identify the product status: FDA-approved branded medication, individualized compounded prescription, cosmetic topical, dietary supplement, or investigational/watchlist compound.

3

Match the route and goal: injection, nasal spray, topical foam or cream, oral product, troche, weight management, recovery, focus, skin, scalp, sexual health, or longevity support.

4

Review safety terms before payment: contraindication, interaction, side effect, adverse event, warning sign, medication list, labs, vitals, pregnancy plans, and clinician follow-up.

5

Use pharmacy terms to spot red flags: patient-specific label, strength, storage, lot or batch, beyond-use date, prescription requirement, and clear pharmacy contact path.

Direct answer

The most important peptide therapy terms are active ingredient, route, indication, FDA-approved label, compounded prescription, contraindication, side effect, pharmacy label, beyond-use date, and follow-up plan. Patients should use these terms to compare the exact product being discussed—not rely on broad peptide claims, seller acronyms, or copied dosing charts.

Medication identity

Define the exact product before comparing peptide options

Many online pages use “peptide therapy” as a catch-all phrase. A safer conversation names the exact active ingredient, brand or compounded status, route, intended use, and evidence limits. Semaglutide and tirzepatide are not the same as sermorelin, PT-141/bremelanotide, glutathione, NAD+, GHK-Cu topical foam, or low-dose oral methylene blue.

  • Active ingredient means the molecule being prescribed or discussed, not the clinic package name or influencer shorthand.
  • Route means how the product is used, such as injection, nasal spray, topical foam, face cream, oral tablet/capsule, or troche; route changes can change screening and follow-up.
  • Indication means the labeled or intended medical use. A product approved for one use should not be marketed as proven for every wellness, weight-loss, anti-aging, or performance goal.

Status and sourcing

Compounded, branded, cosmetic, and supplement are not interchangeable terms

Patients should separate FDA-approved branded medicines, individualized compounded prescriptions, cosmetics, and dietary supplements before comparing claims. Compounded medications can be appropriate for an individual prescription in some circumstances, but they are not FDA-approved finished drug products. Supplements and cosmetics have different oversight and should not be treated as prescription substitutes.

  • Branded products such as Wegovy, Ozempic, Zepbound, Mounjaro, and Vyleesi have FDA-reviewed labels for specific uses, warnings, and patient groups.
  • Compounded prescriptions should come from legitimate pharmacy channels with patient-specific directions, storage instructions, beyond-use dating, and prescriber oversight.
  • No-prescription checkout, research-use vials marketed for human use, hidden pharmacy sourcing, and guaranteed-result claims are red flags.

Safety language

Good glossary terms should change the care questions you ask

Useful terms are not trivia; they help patients ask safer questions. Contraindications, interactions, adverse events, warning signs, lab context, side-effect reporting, pharmacy substitutions, and refill rules all affect whether an online peptide plan is medically appropriate and how follow-up should happen.

  • Contraindication means a reason a treatment may be unsafe or inappropriate for a patient because of diagnosis, history, pregnancy context, allergy, medication, or risk profile.
  • Interaction means one product, prescription, supplement, alcohol pattern, or medical condition may change the risk or effect of another product.
  • Follow-up plan means how results, side effects, labs or vitals when relevant, refills, dose-change questions, shipment problems, and urgent symptoms are handled after prescribing.

Patient safety checklist

Glossary questions to bring to an online peptide therapy visit

These points are educational and do not replace medical advice. A licensed clinician should review individual history, medications, risks, and state-specific availability before treatment.

What is the exact active ingredient, route, strength or concentration, brand name, and compounded status?

Is this product FDA-approved for my specific indication, used off-label, compounded for an individual prescription, cosmetic, supplement-adjacent, or investigational?

What contraindications, drug interactions, allergies, pregnancy plans, medical history, labs, blood pressure, glucose context, or side-effect history should be reviewed?

Which pharmacy or manufacturer supplies the product, and will the label show patient-specific directions, storage, lot or batch details, and a beyond-use or expiration date?

What symptoms should be reported through the portal, handled by the pharmacy, reviewed the same day, treated as urgent, or directed to emergency care or poison control?

How are refills, dose-change questions, missed doses, delayed shipments, warm packages, adverse events, and stopping rules handled?

Which lower-risk, non-peptide, branded, specialist, primary-care, nutrition, dermatology, sexual-health, or in-person alternatives should be considered first?

Which claims should I ignore because they are based on seller acronyms, research-use products, social media stacks, or guaranteed outcomes?

FAQs

Short answers for patients

What does active ingredient mean in peptide therapy?

Active ingredient means the specific molecule being prescribed or discussed, such as semaglutide, tirzepatide, sermorelin, bremelanotide, glutathione, NAD+, GHK-Cu, or methylene blue. Patients should compare active ingredients, not only clinic package names or peptide acronyms.

What does compounded peptide medication mean?

A compounded medication is prepared for an individual prescription by a pharmacy when clinically appropriate and legally available. It should not be described as an FDA-approved finished drug product, and patients should ask about pharmacy licensing, labeling, storage, beyond-use date, and follow-up.

What is the difference between a side effect and a contraindication?

A side effect is an unwanted symptom or reaction that can happen during treatment. A contraindication is a reason the treatment may be unsafe or inappropriate before starting. Both should be reviewed with the prescribing clinician and documented in the care plan.

What does route mean for peptide therapy?

Route means how a product is used, such as injection, nasal spray, topical foam, face cream, oral product, or troche. Route affects absorption, side effects, storage, supplies, pharmacy questions, and whether a patient should switch only after clinician review.

Why does the pharmacy label matter?

The pharmacy label helps verify the active ingredient, strength, route, directions, storage, prescriber, pharmacy contact information, and beyond-use or expiration details. Patients should not use unclear, unlabeled, research-use, or no-prescription products marketed for human use.

Are peptide therapy acronyms reliable?

Acronyms can be confusing and are not enough for a medical decision. Ask for the full active ingredient, product status, route, intended use, evidence limits, pharmacy source, and clinician follow-up before comparing or starting any product.